< em > Correction to < /em > : Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study'' by Subbiah et al. < em > Thyroid 2024;34(1):26-40 < /em > ; doi: 10.1089/thy.2023.0363

Thyroid. 2024 Apr 16. doi: 10.1089/thy.2023.0363.correx. Online ahead of print.NO ABSTRACTPMID:38625021 | DOI:10.1089/thy.2023.0363.correx
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Source Type: research